Concourse Financial Group Securities’s Immunomedics Inc IMMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-158
Closed -$13K 2409
2020
Q3
$13K Hold
158
﹤0.01% 1509
2020
Q2
$6K Hold
158
﹤0.01% 1647
2020
Q1
$2K Hold
158
﹤0.01% 1976
2019
Q4
$3K Buy
+158
New +$2.79K ﹤0.01% 1848
2019
Q3
Sell
-115
Closed -$1.69K 2262
2019
Q2
$2K Sell
115
-61
-35% -$918 ﹤0.01% 2068
2019
Q1
$3K Buy
+176
New +$2.84K ﹤0.01% 1979

Concourse Financial Group Securities's IMMU Position: Q4 2020 in Review

Concourse Financial Group Securities sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 158 shares — an estimated $13K sold.

Concourse Financial Group Securities first reported a position in IMMU in Q1 2019 and held it in 6 quarters. The position peaked at $13K in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Concourse Financial Group Securities reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Concourse Financial Group Securities sold 158 Immunomedics Inc shares in Q4 2020, an estimated $13K.
  • Concourse Financial Group Securities first reported a position in Immunomedics Inc in Q1 2019 and held it in 6 quarters.
  • Concourse Financial Group Securities's Immunomedics Inc position peaked at $13K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Concourse Financial Group Securities's 13F filing for Q4 2020, filed 2 Feb 2021.